| Deler fremragende | 46,588,709 shares |
| Insideraktier | 5.401.084 shares |
| Insider ejerskab | 11,59 % |
| Total Insiders | 32 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Minerva Neurosciences, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Frederick W Ahlholm SVP, CFO and Secretary - [O] | 17.518 | 17.518 | |
|
Plc Barclays
10% Owner -
|
196.800 | 196.800 | |
|
Boehringer Ingelheim International Gmbh
10% Owner -
|
2.550.000 | 2.550.000 | |
| Marc D Beer Director - [D] | 50.000 | 6.250 | |
|
Care Capital III LLC
10% Owner -
|
1.662.592 | 207.824 | |
|
Care Capital Investments III L.P.
10% Owner -
|
1.662.592 | 207.824 | |
|
Care Capital Offshore Investments III LP
10% Owner -
|
1.662.592 | 207.824 | |
| William F Doyle Director - [D] | 26.111 | 3.264 | |
| Michael Davidson Chief Medical Officer - [O] | 0 | 0 | |
|
Rubertis Francesco De
Director, 10% Owner -
[D]
|
4.690.906 | 586.363 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Hans Peter Hasler Director - [D] | 10.000 | 1.250 | |
| Jeryl L Hilleman Director - [D] | 1.000 | 125 | |
|
Venture Associates III Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
Venture Associates IV Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
Venture Associates V Ltd Index
10% Owner -
|
3.899.189 | 487.399 | |
|
& Johnson Johnson
10% Owner -
|
0 | 0 | |
|
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
0 | 0 | |
| David Kupfer Director - [D] | 163.553 | 20.444 | |
| Fouzia Laghrissi-Thode Director - [D] | 0 | 0 | |
| Levine Mark S. SVP,General Counsel & Sec. - [O] | 0 | 0 | |
| Remy Luthringer CEO, Director - [D] [O] | 184.819 | 184.819 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Michele Ollier
Director, 10% Owner -
[D]
|
4.690.906 | 586.363 | |
|
Lorenzo Pellegrini
Director, 10% Owner -
[D]
|
3.883.212 | 485.402 | |
| Geoff Race President - [O] | 51.324 | 51.324 | |
| Reilly Joseph H. SVP & Chief Operating Officer - [O] | 31.747 | 3.968 | |
| Russell Richard E. President - [O] | 33.770 | 4.221 | |
| Jay Saoud | 100.000 | ||
| Devin Whittemore Smith | 85.000 | ||
| Heek G Jan Van Director - [D] | 20.333 | 2.542 | |
| Nico Vandervelpen Director - [D] | 0 | 0 | |
| Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] | 41.667 | 5.208 | |
|
(Jersey) SLP Yucca
10% Owner -
|
3.899.189 | 487.399 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NERV / Minerva Neurosciences, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NERV / Minerva Neurosciences, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-07 | 3 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | NERV | Common Stock | D | 1.275.000 | ||||||||
| 2023-05-02 | 2023-05-02 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,7600 | -3.641 | -14 | 68.994 | ||||
| 2023-05-02 | 2023-05-01 | 4 | Luthringer Remy | NERV | Common Stock | D | 3,8500 | -23.753 | -91 | 72.635 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Luthringer Remy | NERV | Common Stock | D | 88.077 | 96.388 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Race Geoff | NERV | Common Stock | D | 3,8500 | -22.082 | -85 | 51.324 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Race Geoff | NERV | Common Stock | D | 46.987 | 73.406 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,4800 | -3.580 | -16 | 17.518 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 19.843 | 21.098 | ||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Capital Inc. | NERV | Common Stock, $0.0001 par value per share | I | 196.800 | ||||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Bank PLC | NERV | Common Stock, $0.0001 par value per share | I | 408.430 | ||||||||
| 2022-02-18 | 2022-02-16 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 0,79 | 180.000 | 180.000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 0,79 | 505.000 | 505.000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 0,79 | 200.000 | 200.000 | |||||
| 2021-12-03 | 2021-12-01 | 4 | Kupfer David | NERV | Common Stock | D | 0,8800 | -55.635 | -49 | 163.553 | ||||
| 2021-06-16 | 2021-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 2,90 | 40.000 | 40.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 2,90 | 20.000 | 20.000 | |||||
| 2020-12-16 | 2020-12-16 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 2,6400 | -3.228 | -9 | 31.747 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 34.975 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Race Geoff | NERV | Common Stock | D | 2,6400 | -6.190 | -16 | 211.354 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 217.544 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Luthringer Remy | NERV | Common Stock | D | 2,6400 | -1.300 | -3 | 66.490 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 67.790 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 2,6400 | -1.845 | -5 | 10.039 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 11.884 | ||||||
| 2020-10-14 | 2020-10-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 3,50 | 200.000 | 200.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 3,50 | 140.000 | 140.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 3,50 | 100.000 | 100.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 3,50 | 85.000 | 85.000 | |||||
| 2020-09-11 | 2020-09-10 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 2,9700 | 7.000 | 21 | 20.333 | ||||
| 2020-08-17 | 2020-06-19 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153.531 | 153.531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 275.568 | 275.568 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137.784 | 137.784 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 354.302 | 354.302 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 153.531 | 153.531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 185.025 | 185.025 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 236.202 | 236.202 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 137.784 | 137.784 | |||||
| 2020-06-12 | 2020-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 3,40 | 40.000 | 40.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 3,40 | 20.000 | 20.000 | |||||
| 2020-05-27 | 2020-05-26 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 15,0000 | -8.339 | -125 | 6.884 | ||||
| 2020-01-03 | 2019-12-31 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,11 | 74.432 | 74.432 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41.469 | 41.469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,11 | 49.975 | 49.975 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,11 | 63.798 | 63.798 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,11 | 41.469 | 41.469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37.216 | 37.216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,11 | 37.216 | 37.216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,11 | 95.698 | 95.698 | |||||
| 2019-12-17 | 2019-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,1000 | -5.826 | -41 | 205.044 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 12.500 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 210.870 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,1000 | -2.724 | -19 | 26.225 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 8.750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 28.949 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,1000 | -1.557 | -11 | 15.223 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 5.000 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 16.780 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,1000 | -2.412 | -17 | 49.040 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 18.750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 51.452 | ||||||
| 2019-12-13 | 2019-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,4200 | -3.113 | -23 | 33.770 | ||||
| 2019-07-01 | 2019-06-27 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 5,5000 | 3.500 | 19 | 26.111 | ||||
| 2019-06-27 | 2019-06-26 | 4 | Kupfer David | NERV | Common Stock | D | 5,5500 | 10.000 | 56 | 219.188 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HASLER HANS PETER | NERV | Common Stock | D | 5,6000 | 10.000 | 56 | 10.000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HILLEMAN JERYL L | NERV | Common Stock | D | 5,2500 | 1.000 | 5 | 1.000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 5,3700 | 10.000 | 54 | 13.333 | ||||
| 2019-06-26 | 2019-06-24 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0144 | -197.000 | -1.185 | 3.899.189 | ||||
| 2019-06-21 | 2019-06-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,3413 | -33.575 | -146 | 4.096.189 | ||||
| 2019-06-21 | 2019-06-19 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4425 | -77.243 | -343 | 4.129.764 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4393 | -49.675 | -221 | 4.207.007 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4487 | -56.243 | -250 | 4.256.682 | ||||
| 2019-06-17 | 2019-06-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,4971 | -25.169 | -113 | 4.312.925 | ||||
| 2019-06-17 | 2019-06-13 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5133 | -53.298 | -241 | 4.338.094 | ||||
| 2019-06-13 | 2019-06-12 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,5719 | -26.901 | -123 | 4.391.392 | ||||
| 2019-06-13 | 2019-06-11 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4,7769 | -33.150 | -158 | 4.418.293 | ||||
| 2019-06-13 | 2019-06-12 | 4 | DOYLE WILLIAM F | NERV | Stock option (right to buy) | D | 4,50 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 5,21 | 20.000 | 20.000 | |||||
| 2019-05-21 | 2019-05-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0750 | -200 | -1 | 4.451.443 | ||||
| 2019-05-21 | 2019-05-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,0164 | -22.718 | -137 | 4.451.643 | ||||
| 2019-05-16 | 2019-05-16 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,3715 | -44.836 | -286 | 4.474.361 | ||||
| 2019-05-16 | 2019-05-15 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6,6357 | -53.418 | -354 | 4.519.197 | ||||
| 2019-05-16 | 2019-05-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 7,0548 | -36.574 | -258 | 4.572.615 | ||||
| 2018-12-26 | 2018-12-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 6,5000 | 2.000 | 13 | 22.611 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7,4600 | -2.728 | -20 | 20.199 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 17.500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 22.927 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7,4600 | -2.604 | -19 | 32.702 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 37.500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 35.306 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7,4600 | -1.559 | -12 | 11.780 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 10.000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 13.339 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7,4600 | -5.999 | -45 | 198.370 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 25.000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 204.369 | ||||||
| 2018-12-13 | 2018-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7,9600 | -3.117 | -25 | 36.883 | ||||
| 2018-12-13 | 2018-12-11 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 260.000 | 260.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7,96 | 96.000 | 96.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175.000 | 175.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7,96 | 410.000 | 410.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7,96 | 175.000 | 175.000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7,96 | 120.000 | 120.000 | |||||
| 2018-12-12 | 2018-12-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 7,9500 | 4.000 | 32 | 20.611 | ||||
| 2018-12-12 | 2018-12-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,0000 | 2.000 | 16 | 16.611 | ||||
| 2018-11-21 | 2018-11-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8,2000 | 2.000 | 16 | 14.611 | ||||
| 2018-10-15 | 2018-10-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,0000 | 600 | 6 | 12.611 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -10.000 | 47.524 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -15.000 | 27.400 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,6200 | -1.700 | -21 | 14.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0200 | -23.300 | -280 | 15.877 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,1900 | 10.000 | 52 | 39.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 15.000 | 71 | 29.177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,3509 | -15.444 | -191 | 4.609.189 | ||||
| 2018-10-01 | 2018-09-28 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,6151 | -34.589 | -436 | 4.624.633 | ||||
| 2018-10-01 | 2018-09-27 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12,5702 | -31.684 | -398 | 4.659.222 | ||||
| 2018-09-19 | 2018-09-17 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 1.800 | 19 | 12.011 | ||||
| 2018-09-17 | 2018-09-14 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 200 | 2 | 10.211 | ||||
| 2018-09-17 | 2018-09-13 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10,5000 | 2.000 | 21 | 10.011 | ||||
| 2018-09-11 | 2018-09-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,7200 | 4.011 | 39 | 8.011 | ||||
| 2018-09-11 | 2018-09-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9,8800 | 4.000 | 40 | 4.000 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -25.000 | 42.400 | |||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 10,0000 | -25.000 | -250 | 14.177 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 25.000 | 118 | 39.177 | ||||
| 2018-08-02 | 2018-08-01 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (Righ to Buy) | D | 7,95 | 200.000 | 200.000 | |||||
| 2018-08-02 | 2018-08-01 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 7,95 | 20.000 | 20.000 | |||||
| 2018-07-17 | 2018-07-16 | 4 | HILLEMAN JERYL L | NERV | Stock Option (Right to Buy) | D | 8,20 | 40.000 | 40.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | HASLER HANS PETER | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 8,25 | 20.000 | 20.000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | -12.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,20 | -12.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | 7.500 | 7.500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4,34 | -7.500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127.513 | 127.513 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | -127.513 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | 80.356 | 80.356 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9,49 | -80.356 | 0 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,20 | 200.000 | 200.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12.500 | 37.500 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 5,7900 | -5.829 | -34 | 191.869 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12.500 | 197.698 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 200.000 | 200.000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 175.000 | 175.000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Davidson Michael | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 125.000 | 125.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5.000 | 15.000 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,8000 | -1.661 | -10 | 8.339 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.000 | 10.000 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120.000 | 120.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8.750 | 26.250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5,8000 | -2.906 | -17 | 14.177 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8.750 | 17.083 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 120.000 | 120.000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18.750 | 56.250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 5,8500 | -2.194 | -13 | 16.556 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18.750 | 18.750 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,10 | 350.000 | 350.000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | DOYLE WILLIAM F | NERV | Option Grant (Right to Buy) | D | 5,70 | 40.000 | 40.000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | HASLER HANS PETER | NERV | Option Grant (Right to Buy) | D | 5,70 | 40.000 | 40.000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Employee Stock option (Right to Buy) | D | 6,05 | 775.000 | 775.000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Common Stock | D | 40.000 | 40.000 | ||||||
| 2017-09-14 | 2017-08-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 0,0001 | -3.892.256 | -0 | 0 | ||||
| 2017-09-05 | 2017-09-01 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6,45 | 100.000 | 100.000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | -12.500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,20 | -12.500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | 25.000 | 25.000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4,71 | -25.000 | 0 | |||||
| 2017-06-05 | 2017-06-01 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -7.250 | 49.750 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -14.381 | 43.143 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 11,0000 | -10.381 | -114 | 5.000 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 10,0000 | -11.250 | -112 | 15.381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 7.250 | 34 | 26.631 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,1900 | 14.381 | 75 | 19.381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 5,19 | -17.500 | 39.774 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 11,0000 | -17.500 | -192 | 0 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 17.500 | 91 | 17.500 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10,00 | 12.500 | 12.500 | |||||
| 2017-03-21 | 2017-03-20 | 4 | Beer Marc D | NERV | Common Stock | D | 7,8900 | 25.000 | 197 | 50.000 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Beer Marc D | NERV | Common Stock | D | 8,3400 | 25.000 | 208 | 25.000 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | -2.185 | 285.719 | |||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0000 | -2.185 | -24 | 0 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 2.185 | 10 | 2.185 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4,71 | -32.096 | 287.904 | |||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 11,0200 | -32.096 | -354 | 0 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 4,7100 | 32.096 | 151 | 32.096 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Race Geoff | NERV | Common Stock | D | 11,0000 | -1.692 | -19 | 185.198 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Race Geoff | NERV | Common Stock | D | 11,0200 | -19.758 | -218 | 186.890 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Stock Option (Right to Buy) | D | 4,71 | -1.600 | 67.400 | |||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12,0300 | -1.600 | -19 | 8.333 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4,7100 | 1.600 | 8 | 9.933 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 5,19 | -250 | 57.274 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 4,71 | -17.250 | 51.750 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 12,0000 | -17.500 | -210 | 0 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 5,1900 | 250 | 1 | 17.500 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 4,7100 | 17.250 | 81 | 17.250 | ||||
| 2017-01-05 | 2017-01-03 | 4 | Davidson Michael | NERV | Stock Option (Right to Buy) | D | 11,75 | 145.000 | 145.000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4,71 | -12.000 | 57.000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 12,5100 | -17.000 | -213 | 5.000 | ||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4,7100 | 12.000 | 57 | 22.000 | ||||
| 2016-12-20 | 3 | Davidson Michael | NERV | Common Stock | D | 0 | ||||||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35.000 | 35.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | 20.000 | 20.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 100.000 | 100.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | 50.000 | 50.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 13,45 | 150.000 | 150.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | 75.000 | 75.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 60.000 | 60.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | 35.000 | 35.000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 13,45 | 35.000 | 35.000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Restricted Stock Units | D | 20.000 | 20.000 | ||||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | -202.634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 5,7720 | 202.634 | 1.170 | 4.690.906 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 10,0000 | -1.000.000 | -10.000 | 4.488.272 | ||||
| 2016-06-21 | 2016-06-21 | 4 | Kupfer David By wife | NERV | Common Stock | I | 10,7250 | 27.935 | 300 | 27.935 | ||||
| 2016-06-21 | 2016-06-20 | 4 | Kupfer David | NERV | Common Stock | D | 10,9530 | 27.700 | 303 | 209.188 | ||||
| 2016-06-17 | 2016-06-16 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 10,20 | 12.500 | 12.500 | |||||
| 2016-03-18 | 2016-03-17 | 4 | Kupfer David | NERV | Common Stock | D | 5,5100 | 181.488 | 1.000 | 181.488 | ||||
| 2016-02-12 | 2015-03-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,9300 | 607.903 | 2.997 | 3.892.256 | ||||
| 2015-12-08 | 2015-12-04 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 4,71 | 175.000 | 175.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 4,71 | 320.000 | 320.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 4,71 | 69.000 | 69.000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 4,71 | 25.000 | 25.000 | |||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 2015-11-02 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5,41 | 25.000 | 25.000 | |||||
| 2015-06-18 | 2015-06-17 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 25.000 | 25.000 | ||||||
| 2015-05-18 | 3 | Laghrissi-Thode Fouzia | NERV | Common Stock | D | 0 | ||||||||
| 2015-04-16 | 2015-02-02 | 4/A | Beer Marc D | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-04-16 | 2015-04-14 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 5,19 | 213.133 | 213.133 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 5,19 | 399.623 | 399.623 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 5,19 | 57.524 | 57.524 | |||||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 6,2500 | -6.700 | -42 | 1.662.592 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,7500 | -1.200.000 | -6.900 | 1.669.292 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5,77 | 0,1250 | 202.634 | 25 | 202.634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 4,8100 | 202.634 | 975 | 5.488.272 | ||||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. | NERV | Warrants (right to buy) | I | 5,77 | 0,1250 | 607.903 | 76 | 607.903 | |||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4,8100 | 607.903 | 2.924 | 4.500.159 | ||||
| 2015-02-04 | 2015-02-02 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-02-04 | 2015-02-02 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 7.500 | 7.500 | ||||||
| 2015-01-26 | 2015-01-26 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,0200 | -23.111 | -116 | 2.869.292 | ||||
| 2015-01-26 | 2015-01-23 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1400 | -63.304 | -325 | 2.892.403 | ||||
| 2015-01-26 | 2015-01-22 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,1100 | -395.697 | -2.022 | 2.955.707 | ||||
| 2015-01-08 | 2015-01-08 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,6600 | -70.659 | -400 | 3.351.404 | ||||
| 2015-01-08 | 2015-01-07 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5,8500 | -64.278 | -376 | 3.422.063 | ||||
| 2015-01-08 | 2015-01-06 | 4 | Care Capital III LLC | NERV | Common Stock | I | 7,9400 | -396.871 | -3.151 | 3.486.341 | ||||
| 2014-09-03 | 2014-09-02 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 7,10 | 93.541 | 93.541 | |||||
| 2014-09-03 | 3 | Vandervelpen Nico | NERV | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6.568.706 | ||||||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 207.869 | 649.842 | |||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 441.973 | 441.973 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6,00 | 127.513 | 127.513 | |||||
| 2014-07-09 | 2014-07-01 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 6,0000 | 3.333 | 20 | 3.333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 6,00 | 51.967 | 51.967 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 6,0000 | 10.000 | 60 | 10.000 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93.541 | 93.541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 737.500 | 4.425 | 3.883.212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 61.923 | 372 | 3.145.712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6,0000 | 114.078 | 684 | 3.083.789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Vivaldi Coelho Rogerio | NERV | Common Stock | D | 6,0000 | 41.667 | 250 | 41.667 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Vivaldi Coelho Rogerio | NERV | Employee Stock Option (right to buy) | D | 6,00 | 498.621 | 498.621 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Race Geoff | NERV | Common Stock | D | 6,0000 | 33.333 | 200 | 206.648 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 249.442 | 346.585 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 97.143 | 97.143 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 6,0000 | 8.333 | 50 | 8.333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6,00 | 93.541 | 93.541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 737.500 | 4.425 | 3.883.212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 61.923 | 372 | 3.145.712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6,0000 | 114.078 | 684 | 3.083.789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -61.922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6,00 | 6,0000 | -114.077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 333.333 | 2.000 | 5.285.638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 1.287.500 | 7.725 | 4.952.305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 61.922 | 372 | 3.664.805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6,0000 | 114.077 | 684 | 3.602.883 | ||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346.630 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346.630 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1.853.208 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1.853.208 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5.939.422 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6.873.796 |
